PDPK1 and lung carcinoma: BBR can significantly inhibit the growth of lung cancer cells by reducing the protein expression of transcription factors Sp1 and 3-phosphoinositide dependent protein kinase 1 (PDPK1), both of which are related to cancer growth and progression (Zheng et al., 2018a).